Latest Breaking News On - Spirit molecule - Page 1 : vimarsana.com

Science Versus Experience in Psychedelic Research

Science Versus Experience in Psychedelic Research
rollingstone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rollingstone.com Daily Mail and Mail on Sunday newspapers.

Rick strassmanTerrence mckennaRolling stone culture councilUniversity of new mexicoBeat generationLost without theNew mexicoSpirit molecule

Algernon NeuroScience and the Centre for Human Drug

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT:.

Noord hollandUnited kingdomBritish columbiaChristopherj moreauRick strassmanAlgernon pharmaceuticals incConstraint induced movement therapyAlgernon pharmaceuticalsCentre for human drug researchSeyltx incInterdisciplinary conference on psychedelic researchCompany phaseAlgernon neuroscienceHuman drug researchInterdisciplinary conferencePsychedelic research

Speaking to people who found God after taking psychedelics

Speaking to people who found God after taking psychedelics
dazeddigital.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dazeddigital.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesRick strassmanRoland griffithsTextbrit dawsonillustrationcallum abbottMuseum of natural history in los angelesJohn hopkins universityRoman catholicSpirit moleculeNatural historyBurning bushAcacia bush

Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), has completed a feasibility study and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study. AGN Neuro is the world’s first company to investigate DMT for the tre

British columbiaUnited kingdomCity ofChristopherj moreauEdmundj safraDavid nuttRick strassmanAlgernon pharmaceuticalsAlgernon pharmaceuticals incConstraint induced movement therapyCentre for human drug researchImperial college londonCompany phaseAlgernon neuroscienceSpirit moleculePsychedelic handbook

Is your church ready for the spiritual revolution of LSD, DMT and magic mushrooms?

“I have personally spoken to many whose experiences have pushed them to become religious seekers.”

United statesCosta ricaWilliam richardAlbert hofmannShane maussRick strassmanJohns hopkinsJesus christCharles taylorDuke divinity schoolNew agePsychedelic renaissanceSpirit moleculeSacred knowledgePsychedelic theology